Empowering Underserved Communities and Advancing Health Equity Through Innovation
Pioneering TCM Research in China for Vector-Borne Disease Prevention
Supported by the Gates Foundation and in collaboration with SIOC and China CDC, Landcent is developing a new natural compound to prevent vector-borne infectious diseases using traditional Chinese herbal medicines. The Gates Foundation's dedication to global health aligns with our mission, working with partners worldwide to identify issues, find solutions, and drive change.
By supporting innovative ideas and recognizing the inherent risks, the foundation enables us to pursue groundbreaking research and development. This collaborative effort enhances our ability to overcome obstacles that prevent people from living their best lives and helps us make significant progress in global health.
Investor
Bill & Melinda Gates Foundation on why they backed Landcent
“(for the) enhancement of the grantee's reputation as an innovator company”.
On June 4th, 2021, Mr. Bill Gates spoke at the Shanghai Pujiang Innovation Forum, emphasizing the positive cooperation between Landcent and the Gates Foundation, as well as his investment in Landcent, (Grantee company).
Our partnerships with the Shanghai Institute of Organic Chemistry (SIOC), the China Academy of Sciences and the likes bolster our research with unparalleled expertise and resources. Collaborating with these prestigious institutions enhances our ability to innovate and drive significant advancements in malaria eradication and enables us to address global health challenges more effectively to make a meaningful impact on disease control and prevention.
We work with
Driving Health Innovations with Gates Foundation Funding
_edited.jpg)
Landcent is dedicated to creating innovative solutions that advance health equity and address unique health challenges in areas burdened by poverty-related diseases.
In 2017, we earned membership in the World Health Organization's Global Collaboration for Development of Pesticides for Public Health (GCDPP), propelling our expansion into the pharmaceutical sector and enhancing our commitment to sustainable health improvements.
"Driving Health Innovations" stands as a testament to a tangible shift in global health dynamics, realized through the significant support of the Gates Foundation.
We strive to create a world where every community can thrive.
Sharing Space with a Nobel Prize Winner
Tu Youyou was awarded the Nobel Prize in Physiology or Medicine in 2015 for her discoveries of a novel therapy against malaria. The Lasker Foundation awarded her the Clinical Medical Research Award in 2011, calling the discovery of artemisinin "arguably the most important pharmaceutical intervention in the last half-century." Artemisinin has saved countless lives and remains a key remedy for malaria.
In May 2016, SIOC and Landcent established a joint laboratory to prevent and control major communicable diseases in Africa. Founded in 1950, SIOC is one of the first 15 institutes of the Chinese Academy of Sciences (CAS) and partnered with Tu Youyou to develop artemisinin.
The Poverty-Health Nexus
Poor health impairs an individual's capacity to work, learn, and manage daily activities, diminishing their earning potential and leading to poverty. This vicious cycle of poverty and illness entraps communities.
Landcent addresses this by prioritizing health equity and creating innovative health solutions tailored to impoverished regions.
By tackling health disparities, Landcent aims to enhance community health outcomes, break the poverty barrier and promote a cycle of sustained health and economic growth.
